Form D — EIKONOKLASTES THERAPEUTICS, INC.
0001805698-25-000002 · filed 2025-07-29
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $15,764,780
- Total sold
- $13,555,109
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- EIKONOKLASTES THERAPEUTICS, INC.
- CIK
- 1805698
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2356 PARK AVENUE
CINCINNATI, OH 45206 - Phone
- (513) 549-6484
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Bruce Halpryn · Executive OfficerCincinnati, OH Find on LinkedIn ↗
-
Samuel Lee · Executive OfficerCincinnati, OH Find on LinkedIn ↗
-
Kenneth Morand · DirectorCincinnati, OH Find on LinkedIn ↗
-
Thomas Finn · DirectorCincinnati, OH Find on LinkedIn ↗
-
Robert Johnson · DirectorCincinnati, OH Find on LinkedIn ↗
-
Joseph Nolan · DirectorCincinnati, OH Find on LinkedIn ↗
View original on SEC EDGAR.